Who has invested in CoMind?

Plural are named among the investors backing CoMind.

CoMind Funding: $103M Raised, Series A (2025)

CoMind funding overview

CoMind is a Biotech company based in London, United Kingdom. CoMind has raised $103M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in January 2025. The round record for CoMind runs through 2025; nothing later has been disclosed. Investors on record include Plural.

CoMind at a glance

Total raised: $103M
Latest round: Series A
Latest round date: January 2025
Industry: Biotech
Headquarters: London, United Kingdom
Notable investors: Plural

Frequently asked about CoMind funding

How much has CoMind raised?: CoMind has raised $103M in total disclosed funding across the rounds on record.
Who has invested in CoMind?: Plural are named among the investors backing CoMind.
What was the latest CoMind funding round?: The most recent disclosed round is a Series A, announced in January 2025.
Where is CoMind based?: CoMind is based in London, United Kingdom.
What sector does CoMind operate in?: CoMind is tracked under Biotech from London, United Kingdom, with $103M in disclosed funding.
When did CoMind last raise?: The last disclosed CoMind round closed in January 2025 at Series A.

Round data for CoMind is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in London and backer lists below.

CoMind Funding: $103M Raised, Series A (2025)

CoMind funding overview

CoMind at a glance

Frequently asked about CoMind funding

Companies related to CoMind (40)

Browse related funding lists (6)